Catalog excerpts
WUHAN YZY MEDICAL SCIENCE AND TECHNOLOGY CO.,LTD. Address: 4th & 5th floor. Unit 1, Building 23, Phase 1& 2 , Wuhan Optics Valley International Bio-pharmaceutical Enterprise Accelerator, 388 Gaoxin 2nd Road, Optics Valley, East Lake Hi-Tech Development Zone, Wuhan, Hubei, R.R.China 430075 Tel: 400-8013-133 Email: info@yzymedical.com Website: www.yzymed.com WUHAN YZY MEDICAL SCIENCE AND TECHNOLOGY CO.,LTD.
Open the catalog to page 1CTCBIOPSY® PLATFORM PHARMACOGENOMICS CTCBIOPSY* PLATFORM Lung Cancer Colorectal Cancer Thyroid Cancer Melanoma Pharmacogenomics Targeted companion solutions CTCBIOPSY* Autoanalyzer System-AI 0 CCTCBIOPSY* Separation & Staining Instrument-DlOO CTCBIOPSY* Scanning System-D800 RAPIDFISH® SOLUTIONS RAPIDFISH* SOLUTIONS Lymphoma -Bladder Cancer Myelodysplastic Syndrome Leukemia Soft Tissue Tumor Breast Cancer Prenatal Diagnosis CTCBIOPSY* Platform ^ RapidFISH® Solutions!
Open the catalog to page 2THE RIGHT DRUG FORTHE RIGHT PATIENT jlSLCOIBI/APOE Gene Polymorphism Detection Kit Pharmacogenetics Testing Individualization of drug therapy, described as tailoring drug selection and drug dosing to a given patient, has been an objective of physicians and other health-care providers for centuries. An understanding of the pathogenesis of the disease, the mechanism of action of the drug, and exposure-response relationships provides the framework for individualization.The goal of individualization is to optimize the efficacy of a drug, minimize its toxicity, or both.YZY MED takes "The right...
Open the catalog to page 3THE RIG HTDRU G F ORTHE RIGHTPAT1 ENT THE RIGHT DRUG FOR THE RIGHT PAT ENT ■ Corresponding drugs: Clopidogrel, omeprazole, diazepam, phenytoin sodium, etc ■ Drug Background CYP2C19 is one of the most important drug metabolism enzymes in CYP450 family. Studies have found that CYP2C19 can affect the metabolism of many important clinical drugs such as clopidogrel, omeprazole, diazepam, phenytoin sodium, and its gene polymorphism is one of the important reasons for the different metabolic ability of the same drug between individuals and races. The detection of CYP2C19 genotype can determine the...
Open the catalog to page 4THE RIG HTDRU G F OR THE RIG HTPA71 ENT THE Rl GHT DRUG FO R THE Ri GHT PATI ENT THE RIG HTDRU G F OR THE RIG HTPA71 ENT THE Rl GHT DRUG FO R THE Ri GHT PATI ENT JALDH2 Gene Polymorphism Detection Kit ]lcYP2C9/VKORC1 Gene Polymorphism Detection Kit ■ Corresponding drugs: Warfarin, ibuprofen ■ Drug Background Warfarin is a widely used oral anticoagulant in clinical practice. However, warfarin dosing is difficult to master. Bleeding side effects occur in 15.2% of patients taking warfarin each year. CYP2C9 and VKORC1 gene polymorphisms are closely related to anticoagulant efficacy, and...
Open the catalog to page 5T HE RIG HTDRU G F OR THE RIG HTPAT1 ENT THE RIGHT DRUG FOR THE RIGHT PATIENT T HE RIG HTDRU G F OR THE RIG HTPAT1 ENT THE RIGHT DRUG FOR THE RIGHT PATIENT AGTR1/ACE/ADRB1/CYP2D6/CYP2C9 Gene Polymorphism Detection Kit ^jHLA-B*5801 Gene Polymorphism Detection Kit ■ Corresponding drugs: Angiotensin II receptor blockers, beta-adrenergic receptor blockers, angiotensin converting enzyme inhibitors,etc. ■ Drug Background The prevalence of hypertension is obviously increasing in recent years. For the treatment of hypertension, a variety of antihypertensive drugs are usually taken at the same time...
Open the catalog to page 6THE RIGHT DRUG FORTHE RIGHT PAT ENT | Lung Cancer Solutions Targeted companion solutions Lung cancer is one of the most common malignant tumors. The occurrence of lung cancer is the result of the accumulation of mutations in dozens of genes (including oncogenes, tumor suppressor genes, etc.) under the influence of in vivo and in vitro factors. Among them, a few genes such as EGFR, EML4-ALK, ROS1, KRAS, BARF, etc. play a key role in the occurrence and progression of tumors. Osimertinib, Almonertinib, Gefitinib, Erlotinib, Icotinib, Dakotinib, Afatinib Alectinib, Crizotinib, Ceritinib...
Open the catalog to page 7T HE RIG HTDRU G F ORT HE RIG HTPAT1ENT THE Rl GHT DRUG FO R THE Rl GHT PATI ENT Colorectal cancer is one of the most common digestive system tumors, and its incidence ranks among the top three in the world.Because there are no obvious symptoms in the early stage, colorectal cancer is often not diagnosed until the advanced stage, which has been called the "silent killer".With the development of the concept of precision medicine and the research on tumor-related molecular markers, the reasonable detection and application of colorectal cancer related molecular markers has become an important...
Open the catalog to page 8CTCBIOPSY® Platform Melanomas are the most aggressive skin cancers. According to statistics, in 2020, there were 325,000 new cases of cutaneous melanoma and 57,000 deaths worldwide.According to the guidelines, all patients need to undergo genetic testing before treatment, which can provide individualized guidance for patient treatment and prognosis. Detection Significance Test Item To guide vemurafenib targeted therapy To guide the targeted therapy of dabrafenib combined with trametinib To guide the prognostic effect of melanoma patients ■ Application • All patients with melanoma....
Open the catalog to page 9THE RIG HTDRU G FORTHE RIG HTPATI ENT THE RIGHT DRUG FORTHE RIGHT PATIENT CTCBIOPSY® Autoanalyzer system A10 is an automated instrument for abnormal blood cells analysis. By using a microporous filtration device made of polymer materials, the instrument can quickly and accurately separate circulating tumor cells from blood cells based on the differences in physical characteristics such as size, deformation ability, and fluid dynamics between CTC and blood cells. Combined with Wright-Giemsa staining solution, the morphology of CTC and CTM could be observed under an ordinary optical...
Open the catalog to page 10rc^818181888818* Based on the pathological work Circulating Tumor Cell Pathology Map and Application, through the perfect combination of automated digital pathological scanning platform and Al intelligent learning system, the first circulating tumor cell morphology identification platform in China was created. CTCBIOPSY® CIRCULATING TUMOR CELL SCANNING SYSTEM-D800 Automatic and efficient Sample capacity:5 slides/time, 10 min/slide, CTC automatic scanning Tumor has gradually become one of the main causes of human death. Early diagnosis of tumor is of great help to the treatment. In the past,...
Open the catalog to page 11